EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Cost-effectiveness analysis of reflex p16/Ki-67 dual-stained cytology in HPV partial genotyping screening in Singapore

Sun Kuie Tay iD, David Wastlund iD, Rebecca Shu Yu Sim iD, James Karichu iD, Qishi Zheng iD

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e115 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Sun Kuie Tay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore. tay.sun.kuie@singhealth.com.sg. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Papillomavirus Infections, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Roche Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Triage testing is an integral part of high-risk human papillomavirus (HPV)-based cervical screening programs. This study assesses, from a healthcare payer perspective in Singapore, the cost-effectiveness of p16/Ki-67 dual-stained cytology (DS) compared to current standard of care (SOC). METHODS: A decision-analytic Markov microsimulation model with a lifetime horizon was built to simulate the outcomes from HPV screening in Singaporean women aged 30-65 years. The intervention (primary testing with HPV genotyping followed by DS reflex test) was compared to current SOC (HPV genotyping followed by cytology) according to Singaporean clinical management guidelines. The progression through health states and associated costs and health outcomes were based on local clinical care data in Singapore. Screening impact was assessed by cost saving, number of colposcopy and quality-adjusted life years (QALYs). RESULTS: Compared to SOC, implementation of HPV genotyping + DS was estimated to decrease the number of screening test (-2.02 times per patient) and colposcopy (-0.16 times per patient), and reduce the overall costs to the Singaporean healthcare system by S$225.59 per patient (95% confidence interval [CI]=S$199.05 to S$249.99). The total QALYs estimates for the 2 approaches were similar (-0.0003; 95% CI=-0.0031 to 0.0022). Sensitivity analyses confirmed the robustness of expected cost-savings and that the full value of avoided colposcopies may be larger than projected in the current analysis. CONCLUSION: This economic modelling analysis projected that using DS instead of conventional cytology as the reflex test for positive test with non-HPV-16/18 subtypes significantly reduced the financial costs of cervical cancer screening in Singapore.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Effectiveness AnalysisPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsEarly Detection of CancerKi-67 AntigenCyclin-Dependent Kinase Inhibitor p16Genotyping TechniquesSingaporeMarkov ChainsHuman Papillomavirus VirusesHumansFemaleAdultMiddle AgedAgedCervix UteriColposcopyCost SavingsQuality-Adjusted Life Years

Stichwörter der Autor:innen

Cervical cancerColposcopyEconomic ModelHuman Papillomavirus

Substanzen

Ki-67 AntigenMKI67 protein, humanCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore. tay.sun.kuie@singhealth.com.sg.
  • Vista Health Ltd Pty, Singapore.
  • Roche Molecular Systems, Inc., Singapore.
  • Roche Diagnostics Asia Pacific Pte Ltd., Singapore.

ORCID-Profile: Sun Kuie Tay, David Wastlund, Rebecca Shu Yu Sim, James Karichu, Qishi Zheng

Förderung

  • Roche Diagnostics

Zitieren

APA

Tay, S. K., Wastlund, D., Sim, R. S. Y., Karichu, J., & Zheng, Q. (2025). Cost-effectiveness analysis of reflex p16/Ki-67 dual-stained cytology in HPV partial genotyping screening in Singapore. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e115

Vancouver

Tay SK, Wastlund D, Sim RSY, Karichu J, Zheng Q. Cost-effectiveness analysis of reflex p16/Ki-67 dual-stained cytology in HPV partial genotyping screening in Singapore. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e115

BibTeX
@article{Tay2025,
  author = {Tay, Sun Kuie and Wastlund, David and Sim, Rebecca Shu Yu and Karichu, James and Zheng, Qishi},
  title = {Cost-effectiveness analysis of reflex p16/Ki-67 dual-stained cytology in HPV partial genotyping screening in Singapore},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e115}
}
Kostenlos starten →